Novartis is further evaluating Femara compared to tamoxifen in the adjuvant setting.
Novartis is further evaluating Femara compared to tamoxifen in the adjuvant setting.
弗隆用作辅助药时，诺华以他莫昔芬为对照，对它做了进一步的评估。
Novartis is further evaluating Femara compared to tamoxifen in the adjuvant setting.
弗隆用作辅助药时，诺华以他莫昔芬为对照，对它做了进一步的评估。